跳到正文
Rohan Paul· @rohanpaul_ai · X·· 2 小时前AI 评分43
AI 导读

一个 AI 系统刚刚设计出了比模型所属实验室打造的专用工具更好的分子模型。 @intology 的 Locus 完成了机器学习研究员的工作: > 提出实验, > 在 GPU 上并行运行多批实验 > 保留有效方案并重复, > 现已应用于药物和抗体设计。 Locus 在分子预测上击败了 GPT-6 Astra 和 Claude Opus 5.5 智能体

正文 · 原文

An AI system just designed better molecular models than the specialist tools built by the labs that own those models.

@intology’s Locus does a machine-learning researcher’s job:
> proposes experiments,
> runs many batches of them in parallel on GPUs
> keeps what works and repeats,
> now applied to drug and antibody design.

Locus beat GPT-6 Astra and Claude Opus 5.5 agents on molecular prediction

引用Intology@intology
Locus sets the frontier for automating molecular design Our automated research system Locus develops scientific AI models that outperform SOTA expert solutions Unlocking the potential of scientific AI requires leveraging proprietary data. Locus achieves this autonomously 🧵👇 -- We test Locus across a number of tasks related to molecular scoring and design: training molecular property prediction models for a proprietary task, fine-tuning Boltz-2 to predict small-molecule potency, and building antibody design workflows around BoltzGen, Boltz-2, ESMC, and ESMFold2. Each of these settings are real-world AI for science use cases, where tasks are often out-of-distribution for existing foundation models and limited in data, while featuring expensive and noisy evaluators. Compared to state-of-the-art baselines and LLM agents set to optimize these tasks, Locus achieves higher performance. Additionally, Locus generalizes better despite limited data, finds more sample efficient solutions, and explores a higher diversity of solutions.
在 X 查看被引用的帖子

来源:Rohan Paul · x.com